Deurali-Janta with a vision to expand its product portfolio to Chronic Disease Management therapies and cater the ever-increasing demand of these medicines, introduced SUSWASTHYA in the year 2062, Bhadra. In an effort to help develop population-specific prevention and management strategies and meet HealthCare challenges in the field of Cardiology and Diabetology, SUSWASTHYA with its up-to-date product portfolio, stays in support. With a mission to save lives SUSWASTHYA offers quality, efficacy and reliability at reasonable and affordable price.